Summit Therapeutics IncNASDAQ:SMMT
- LAST PRICE4.4700
- TODAY'S CHANGE (%)0.0800 (1.8223%)
- Bid / Lots4.4500/ 1
- Ask / Lots4.4900/ 20
- Open / Previous Close4.4000 / 4.3900
- Day Range
- 52 Week Range
- Volume1,323,631
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SMMT |
|---|---|---|
| 09:32 ET | 14878 | 4.49 |
| 09:34 ET | 9781 | 4.52 |
| 09:36 ET | 3380 | 4.49 |
| 09:38 ET | 3323 | 4.46 |
| 09:39 ET | 2200 | 4.43 |
| 09:41 ET | 5805 | 4.455 |
| 09:43 ET | 1401 | 4.482 |
| 09:45 ET | 3341 | 4.405 |
| 09:48 ET | 3474 | 4.405 |
| 09:50 ET | 3988 | 4.385 |
| 09:52 ET | 2561 | 4.415 |
| 09:54 ET | 3138 | 4.405 |
| 09:56 ET | 933 | 4.415 |
| 09:57 ET | 1242 | 4.41 |
| 09:59 ET | 2217 | 4.43 |
| 10:01 ET | 2000 | 4.405 |
| 10:03 ET | 200 | 4.405 |
| 10:06 ET | 5122 | 4.43 |
| 10:08 ET | 900 | 4.435 |
| 10:10 ET | 1208 | 4.425 |
| 10:12 ET | 1534 | 4.405 |
| 10:14 ET | 430 | 4.41 |
| 10:15 ET | 600 | 4.4101 |
| 10:19 ET | 1414 | 4.405 |
| 10:21 ET | 100 | 4.405 |
| 10:24 ET | 5513 | 4.45 |
| 10:26 ET | 1216 | 4.44 |
| 10:28 ET | 2107 | 4.43 |
| 10:30 ET | 600 | 4.435 |
| 10:32 ET | 8461 | 4.435 |
| 10:33 ET | 1961 | 4.41 |
| 10:35 ET | 3762 | 4.406 |
| 10:37 ET | 1068 | 4.405 |
| 10:39 ET | 800 | 4.4093 |
| 10:42 ET | 2169 | 4.4025 |
| 10:44 ET | 2444 | 4.38 |
| 10:46 ET | 870 | 4.385 |
| 10:48 ET | 1880 | 4.3725 |
| 10:50 ET | 2473 | 4.38 |
| 10:51 ET | 300 | 4.375 |
| 10:53 ET | 933 | 4.365 |
| 10:55 ET | 7744 | 4.345 |
| 10:57 ET | 200 | 4.35 |
| 11:00 ET | 563 | 4.35 |
| 11:02 ET | 2861 | 4.322 |
| 11:04 ET | 1350 | 4.3388 |
| 11:06 ET | 4422 | 4.345 |
| 11:08 ET | 2247 | 4.36 |
| 11:09 ET | 326 | 4.35 |
| 11:11 ET | 1076 | 4.345 |
| 11:13 ET | 1700 | 4.33 |
| 11:15 ET | 800 | 4.35 |
| 11:18 ET | 550 | 4.34 |
| 11:20 ET | 1200 | 4.355 |
| 11:22 ET | 3052 | 4.35 |
| 11:24 ET | 3272 | 4.345 |
| 11:26 ET | 2900 | 4.345 |
| 11:27 ET | 9145 | 4.37 |
| 11:29 ET | 2024 | 4.375 |
| 11:31 ET | 1800 | 4.39 |
| 11:33 ET | 4626 | 4.385 |
| 11:36 ET | 4400 | 4.3926 |
| 11:38 ET | 7521 | 4.381 |
| 11:40 ET | 900 | 4.38 |
| 11:42 ET | 1925 | 4.38 |
| 11:44 ET | 500 | 4.39 |
| 11:45 ET | 2580 | 4.3862 |
| 11:47 ET | 2500 | 4.4 |
| 11:49 ET | 988 | 4.3911 |
| 11:51 ET | 3900 | 4.41 |
| 11:54 ET | 9742 | 4.435 |
| 11:56 ET | 66427 | 4.3999 |
| 11:58 ET | 1181 | 4.39 |
| 12:00 ET | 500 | 4.385 |
| 12:02 ET | 2110 | 4.37 |
| 12:03 ET | 3760 | 4.385 |
| 12:05 ET | 1700 | 4.395 |
| 12:07 ET | 200 | 4.4 |
| 12:09 ET | 5260 | 4.375 |
| 12:12 ET | 25464 | 4.4199 |
| 12:14 ET | 12111 | 4.4 |
| 12:16 ET | 17383 | 4.405 |
| 12:18 ET | 4278 | 4.405 |
| 12:20 ET | 17712 | 4.3886 |
| 12:21 ET | 5625 | 4.4194 |
| 12:23 ET | 1500 | 4.42 |
| 12:25 ET | 3628 | 4.42 |
| 12:27 ET | 5850 | 4.415 |
| 12:30 ET | 1900 | 4.415 |
| 12:32 ET | 1503 | 4.425 |
| 12:34 ET | 1947 | 4.41 |
| 12:36 ET | 2445 | 4.43 |
| 12:38 ET | 700 | 4.44 |
| 12:39 ET | 1592 | 4.44 |
| 12:41 ET | 6085 | 4.45 |
| 12:43 ET | 111156 | 4.445 |
| 12:45 ET | 13286 | 4.45 |
| 12:48 ET | 6988 | 4.44 |
| 12:50 ET | 1097 | 4.4335 |
| 12:52 ET | 2183 | 4.46 |
| 12:56 ET | 1372 | 4.46 |
| 12:57 ET | 10723 | 4.445 |
| 12:59 ET | 3100 | 4.46 |
| 01:01 ET | 1712 | 4.44 |
| 01:03 ET | 500 | 4.44 |
| 01:06 ET | 1977 | 4.44 |
| 01:08 ET | 500 | 4.44 |
| 01:12 ET | 600 | 4.44 |
| 01:14 ET | 763 | 4.44 |
| 01:15 ET | 300 | 4.45 |
| 01:17 ET | 68878 | 4.485 |
| 01:19 ET | 12430 | 4.455 |
| 01:21 ET | 2180 | 4.49 |
| 01:24 ET | 1605 | 4.505 |
| 01:26 ET | 4251 | 4.515 |
| 01:28 ET | 2280 | 4.505 |
| 01:30 ET | 100 | 4.5 |
| 01:32 ET | 4902 | 4.495 |
| 01:33 ET | 796 | 4.4925 |
| 01:35 ET | 2100 | 4.4925 |
| 01:37 ET | 1779 | 4.505 |
| 01:39 ET | 700 | 4.505 |
| 01:42 ET | 27018 | 4.535 |
| 01:44 ET | 10392 | 4.52 |
| 01:46 ET | 900 | 4.51 |
| 01:48 ET | 4232 | 4.4901 |
| 01:50 ET | 26353 | 4.47 |
| 01:51 ET | 466 | 4.47 |
| 01:53 ET | 1800 | 4.48 |
| 01:55 ET | 1100 | 4.495 |
| 01:57 ET | 3994 | 4.49 |
| 02:00 ET | 2697 | 4.49 |
| 02:02 ET | 35916 | 4.485 |
| 02:04 ET | 385 | 4.49 |
| 02:06 ET | 1200 | 4.49 |
| 02:08 ET | 2444 | 4.46 |
| 02:09 ET | 300 | 4.4625 |
| 02:11 ET | 1291 | 4.475 |
| 02:13 ET | 2121 | 4.46 |
| 02:15 ET | 200 | 4.46 |
| 02:18 ET | 1322 | 4.45 |
| 02:20 ET | 2305 | 4.45 |
| 02:22 ET | 3808 | 4.4546 |
| 02:24 ET | 311 | 4.45 |
| 02:26 ET | 300 | 4.4525 |
| 02:27 ET | 892 | 4.4525 |
| 02:29 ET | 800 | 4.45 |
| 02:31 ET | 3132 | 4.435 |
| 02:33 ET | 2194 | 4.4225 |
| 02:36 ET | 2400 | 4.43 |
| 02:38 ET | 100 | 4.435 |
| 02:40 ET | 300 | 4.44 |
| 02:42 ET | 100 | 4.43 |
| 02:44 ET | 1515 | 4.4225 |
| 02:45 ET | 4811 | 4.4227 |
| 02:47 ET | 4211 | 4.425 |
| 02:49 ET | 5257 | 4.42 |
| 02:51 ET | 2004 | 4.415 |
| 02:54 ET | 1900 | 4.425 |
| 02:56 ET | 3225 | 4.445 |
| 02:58 ET | 6957 | 4.435 |
| 03:00 ET | 2200 | 4.43 |
| 03:02 ET | 200 | 4.435 |
| 03:03 ET | 311 | 4.43 |
| 03:05 ET | 226 | 4.43 |
| 03:07 ET | 6091 | 4.445 |
| 03:09 ET | 737 | 4.45 |
| 03:12 ET | 2749 | 4.435 |
| 03:14 ET | 552 | 4.43 |
| 03:16 ET | 3105 | 4.445 |
| 03:18 ET | 337 | 4.445 |
| 03:20 ET | 2497 | 4.425 |
| 03:21 ET | 1108 | 4.425 |
| 03:23 ET | 2508 | 4.435 |
| 03:27 ET | 1113 | 4.435 |
| 03:30 ET | 326 | 4.4325 |
| 03:32 ET | 1023 | 4.44 |
| 03:34 ET | 1000 | 4.43 |
| 03:36 ET | 9498 | 4.445 |
| 03:38 ET | 30868 | 4.425 |
| 03:39 ET | 1652 | 4.425 |
| 03:41 ET | 764 | 4.43 |
| 03:43 ET | 1904 | 4.425 |
| 03:45 ET | 24873 | 4.435 |
| 03:48 ET | 4145 | 4.43 |
| 03:50 ET | 1600 | 4.435 |
| 03:52 ET | 13360 | 4.465 |
| 03:54 ET | 15844 | 4.435 |
| 03:56 ET | 16247 | 4.465 |
| 03:57 ET | 19540 | 4.45 |
| 03:59 ET | 169955 | 4.47 |
May 1, 2024
*DJ Summit Therapeutics 1Q Loss/Shr 6c >SMMT, from 7:00AM ET on Wednesday May 01, 2024 by Dow Jones
7:00AM ET on Wednesday May 01, 2024 by Dow JonesSummit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2024, from 7:00AM ET on Wednesday May 01, 2024 by Dow Jones
7:00AM ET on Wednesday May 01, 2024 by Dow Jones
Apr 24, 2024
Press Release: Summit Therapeutics to Host First Quarter 2024 Financial Results & Operational Progress Call on May 1, 2024, from 4:46PM ET on Wednesday Apr 24, 2024 by Dow Jones
4:46PM ET on Wednesday Apr 24, 2024 by Dow JonesSummit Therapeutics to Host First Quarter 2024 Financial Results & Operational Progress Call on May 1, 2024, from 4:30PM ET on Wednesday Apr 24, 2024 by Dow Jones
4:30PM ET on Wednesday Apr 24, 2024 by Dow Jones
Apr 11, 2024
Summit Therapeutics Appoints Dr. Mostafa Ronaghi, Renowned Executive and Genomicist, to its Board of Directors, from 4:30PM ET on Thursday Apr 11, 2024 by Dow Jones
4:30PM ET on Thursday Apr 11, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Summit Therapeutics Inc | 3.1B | -2.9x | --- |
Apogee Therapeutics Inc | 3.1B | -31.3x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
MoonLake Immunotherapeutics | 2.9B | -58.4x | --- |
IDEAYA Biosciences Inc | 3.2B | -22.0x | --- |
Xenon Pharmaceuticals Inc | 3.3B | -15.8x | --- |
Company Information
Summit Therapeutics Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of patient, physician and caregiver medicinal therapies. The Company's development candidate is ivonescimab, a potential first-in-class bispecific antibody intending to combine the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects of an anti-VEGF compound into a single molecule. It develops ivonescimab in non-small cell lung cancer (NSCLC), specifically launching Phase III clinical trials in the indications such as ivonescimab combined with chemotherapy in patients with epidermal growth factor receptor (EGFR)-mutated, locally advanced or metastatic non-squamous NSCLC who have progressed after treatment with a third-generation EGFR tyrosine kinase inhibitor (HARMONi), and ivonescimab combined with chemotherapy in first-line metastatic squamous NSCLC patients (HARMONi-3). Its ivonescimab is engineered with Akeso's Tetrabody technology.
Contact Information
- Headquarters
- 2882 Sand Hill Road, Suite 106MENLO PARK, CA, United States 94025
- Phone
- 650-460-8308
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board, Co-Chief Executive Officer
- Robert Duggan
- President, Co-Chief Executive Officer, Director
- Mahkam Zanganeh
- Chief Financial Officer
- Ankur Dhingra
- Chief Operating Officer, Director
- Manmeet Soni
- Lead Non-Executive Independent Director
- Kenneth Clark
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.1B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 702.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -1.28 |
EPS | $-1.54 |
Book Value | $0.11 |
P/E Ratio | -2.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
